Screening compound: C21H30N4O5 (P392-3010)

Screening compound: C<sub>21</sub>H<sub>30</sub>N<sub>4</sub>O<sub>5</sub> (P392-3010)
Screening compound: C<sub>21</sub>H<sub>30</sub>N<sub>4</sub>O<sub>5</sub> (P392-3010) alternative view

Chemical Structure Depiction of ChemDiv screening compound
C21H30N4O5 (P392-3010)

Available from 1 mg

Formats:

  • Glass Vials (4ml Glass Vials VWR #97047-678)
  • 96-tube racks (Matrix #4247 96-well 1.4ml sealed with capmats, empty cols 1 & 12, 100uL of 10mM)

Shiptime: 1 week worldwide delivery in most cases

Compound Identifiers

ChemDiv Compound ID

P392-3010

Molecular Formula

C21H30N4O5 (C21 H30 N4 O5)

Compound Name

ethyl 3-[(3-{[3-(piperidine-1-carbonyl)pyridin-2-yl]oxy}pyrrolidine-1-carbonyl)amino]propanoate

IUPAC name

ethyl 3-[(3-{[3-(piperidine-1-carbonyl)pyridin-2-yl]oxy}pyrrolidine-1-carbonyl)amino]propanoate

SMILES

CCOC(CCNC(N(CC1)CC1Oc1ncccc1C(N1CCCCC1)=O)=O)=O

InChI

InChI=1S/C21H30N4O5/c1-2-29-18(26)8-11-23-21(28)25-14-9-16(15-25)30-19-17(7-6-10-22-19)20(27)24-12-4-3-5-13-24/h6-7,10,16H,2-5,8-9,11-15H2,1H3,(H,23,28)/t16-/m1/s1

InChI Key

CQSYFPUCBZDTKW-MRXNPFEDSA-N

MDL Number (MFCD)

MFCD28999262

C21H30N4O5 (P392-3010) in Drug Discovery

Included in Screening Libraries

300k Representative Compounds Library (Bemis-Murcko Clustering Algorithm) (286253 compounds)

Ligand-Gated Ion Channels Library (3887 compounds)

PI3K-Targeted Library (17255 compounds)

PPI Helix Turn 3D-Mimetics Library (71298 compounds)

Protein-Protein Interaction Library (218420 compounds)

Alpha-Helix Mimetics Library (25899 compounds)

Inhibitors of beta-Catenin Signaling (7445 compounds)

MCE-18 Trends in Medicinal Chemistry (51288 compounds)

MEF2-HDAC (class II) Modulators Library (5147 compounds)

SH2 PTB Focused Library (6188 compounds)

Included in 1.7M Stock Database

Therapeutical areas:
  • Nervous system
  • Eye
  • Cancer
  • Digestive system
  • Respiratory tract
  • Otorhinolaryngologic
  • Male
  • Female
  • Hemic and lymphatic
  • Skin
  • Cancer
  • Musculoskeletal
  • Female
  • Hemic and lymphatic
  • Cardiovascular
Targets:
  • Ion Channels
  • Kinases
Mechanism of action:
  • PPI modulators
  • PPI modulators
  • PPI modulators
  • PPI modulators
  • Epigenetic
Structure:
  • Mimetics
  • Mimetics

References: we are preparing a list of scientific research reports with C21H30N4O5 (P392-3010) chemical compound. It will be published here after verification.

Frequently Asked Questions

How to purchase chemical compound C21H30N4O5 (P392-3010)?
Check Price and Availability of C21H30N4O5 (P392-3010), then you can add required amount to the Shopping Cart. In the Shopping Cart you can again refine your selection. Once you are sure that it’s exactly what you want you can move forward with the Checkout (to pay online by credit card, or via PayPal), or Request a Quote.
What is the minimum amount of C21H30N4O5 (P392-3010) you sell to drug discovery company or institution?
Available from 1 mg in Glass Vials or 96-tube racks.
Delivery options for C21H30N4O5 (P392-3010)
ChemDiv sends parcels with Express services (UPS, WC).
  • 1–2 days for small orders
  • 2–4 weeks for large selections
Delivery formats for C21H30N4O5 (P392-3010)
  • 0.5–50 mg of dry powder sample in single glass vials, custom vials
  • DMSO solutions frozen 10μl–250μl@10mM (96 and 384 format)

Custom synthesis of C21H30N4O5 (P392-3010) available by request